Synthetic Approaches to the New Drugs Approved During 2018.

Clicks: 353
ID: 105087
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #13 of 122 articles by views in Journal of medicinal chemistry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 122 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities (NCEs) provide insight into molecular recognition while serving as leads for designing future new drugs. This annual review describes the most likely process-scale synthetic approaches to thirty-nine new chemical entities approved for the first time globally in 2018.
Reference Key
flick2020syntheticjournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Flick, Andrew;Leverett, Carolyn A;Ding, Hong Xia;McInturff, Emma L;Fink, Sarah;Helal, Christopher;Deforest, Jacob;Morse, Peter;Mahapatra, Subham;O'Donnell, Christopher J;
Journal Journal of medicinal chemistry
Year 2020
DOI
10.1021/acs.jmedchem.0c00345
URL
Keywords
biological activity anti-tumor antivirus immune regulation structural modification degradation modification graft modification

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.